NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 42 filers reported holding NEON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,890,000 | – | 150,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 9,741,636 | $49,000,000 | 41.06% |
| Partner Investment Management, L.P. | 832,358 | $4,187,000 | 5.23% |
| HARVARD MANAGEMENT CO INC | 505,871 | $2,545,000 | 0.54% |
| Casdin Capital, LLC | 263,344 | $1,325,000 | 0.23% |
| MEITAV INVESTMENT HOUSE LTD | 648,878 | $3,264,000 | 0.20% |
| Hillhouse Capital Management | 399,308 | $2,009,000 | 0.15% |
| PFM Health Sciences, LP | 979,002 | $4,924,000 | 0.13% |
| HHLR ADVISORS, LTD. | 312,500 | $1,572,000 | 0.06% |
| ArrowMark Colorado Holdings LLC | 902,861 | $4,541,000 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 54,954 | $276,000 | 0.01% |